- JP-listed companies
- SanBio Company Limited
- Balance sheet
SanBio Company Limited (4592) Balance sheet
Market cap
¥159.8B
P/E ratio
-28.4x
SanBio develops cell therapy drugs to help patients recover brain and nervous system functions lost due to injury or diseases like Parkinson's and Alzheimer's.
| 2014/01 | 2015/01 | 2016/01 | 2017/01 | 2018/01 | 2019/01 | 2020/01 | 2021/01 | 2022/01 | 2023/01 | 2024/01 | 2025/01 | 2026/01 | |
| Cash and cash equivalents | - | 1,229 | 7,734 | 5,561 | 4,655 | 12,453 | 13,646 | 12,480 | 4,557 | 6,733 | 4,455 | 2,921 | 15,083 |
| Total current assets | - | 1,258 | 8,191 | 6,125 | 5,077 | 13,059 | 14,626 | 13,132 | 5,352 | 6,967 | 4,937 | 3,336 | 15,490 |
| Property, plant and equipment, net | - | 18 | 68 | 148 | 101 | 74 | 124 | 142 | 59 | 48 | 44 | 40 | 69 |
| Marketable securities, non-current | - | - | - | - | - | 829 | 825 | - | - | - | - | - | - |
| Total non-current assets | - | 497 | 80 | 168 | 117 | 917 | 979 | 212 | 159 | 78 | 110 | 112 | 132 |
| Total assets | - | 1,755 | 8,271 | 6,292 | 5,194 | 13,976 | 15,605 | 13,344 | 5,511 | 7,045 | 5,047 | 3,447 | 15,622 |
| Short-term debt | - | 100 | 100 | 100 | - | - | - | 500 | - | - | - | - | - |
| Long-term debt, current | - | - | 800 | 50 | 67 | 33 | 500 | 975 | 513 | 268 | 268 | 268 | 129 |
| Total current liabilities | - | 381 | 1,420 | 547 | 2,107 | 1,067 | 1,175 | 2,469 | 1,463 | 1,090 | 906 | 732 | 534 |
| Total non-current liabilities | - | 1,462 | 485 | 1,150 | 2,233 | 4,000 | 3,500 | 2,525 | 2,013 | 1,526 | 1,349 | 952 | 1,483 |
| Total liabilities | - | 1,842 | 1,905 | 1,697 | 4,340 | 5,067 | 4,675 | 4,994 | 3,476 | 2,616 | 2,255 | 1,684 | 2,017 |
| Retained earnings | - | -3,991 | -4,979 | -6,814 | -10,755 | -13,675 | -9,018 | -7,356 | -9,057 | -8,177 | -1,950 | -699 | -996 |
| Stockholders' equity | -1,963 | -87 | 6,367 | 4,595 | 853 | 8,909 | 10,930 | 8,350 | 2,035 | 4,429 | 2,792 | 1,763 | 13,605 |